Schedule 13G ownership disclosure

CATALYST PHARMACEUTICALS, INC.

Security class unavailable · CUSIP: 14888U101

Event date: 2022-11-04

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
5.8200%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193805-22-001533
Form type
SC 13G
Filer
CATALYST PHARMACEUTICALS, INC.
CIK
CIK 1369568
Filed
Nov 14, 2022
Reporting period
Nov 04, 2022
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub